Get startedLog in
    Picture of Lobe Sciences logo

    LOBE — Lobe Sciences Cashflow Statement

    0.000.00%
    ca flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapNeutral
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Lobe Sciences, fiscal year end - August 31st, CAD millions except per share, conversion factor applied.

    2020
    August 31st
    2021
    August 31st
    2022
    August 31st
    2023
    August 31st
    2024
    August 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line-3.44-22.8-12.3-4.71-4.42
    Depreciation
    Amortisation
    Non-Cash Items1.6717.68.661.432.54
    Discontinued Operations
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital-0.0190.1850.8481.521.33
    Change in Accounts Receivable
    Change in Inventories
    Change in Prepaid Expenses
    Change in Accounts Payable
    Change in Payable / Accrued Expenses
    Change in Taxes Payable
    Cash from Operating Activities-1.22-5.04-2.73-1.72-0.462
    Capital Expenditures—-0.1370——
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items0.1991.21.740—
    Sale of Business
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Change in Net Investments
    Change in Net Intangibles
    Other Investing Cash Flow
    Cash from Investing Activities0.1991.071.740—
    Financing Cash Flow Items0.003-0.198-0.043-0.102—
    Other Financing Cash Flow
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities0.7194.920.7530.950.564
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash-0.3410.97-0.234-0.7670.097